{
    "clinical_study": {
        "@rank": "119353", 
        "acronym": "FrenchAF", 
        "arm_group": [
            {
                "arm_group_label": "Pasteur"
            }, 
            {
                "arm_group_label": "Grenoble"
            }, 
            {
                "arm_group_label": "Nantes"
            }, 
            {
                "arm_group_label": "Parly"
            }, 
            {
                "arm_group_label": "Rennes"
            }, 
            {
                "arm_group_label": "Rouen"
            }
        ], 
        "brief_summary": {
            "textblock": "Atrial fibrillation is the most frequent sustained arrhythmia. Catheter ablation is a\n      procedure that is currently used for the treatment of symptomatic atrial fibrillation\n      patients.\n\n      We have organized a multi-centric national survey of catheter ablation of atrial\n      fibrillation in order to have a feedback on the type of procedures being performed and the\n      overall results (freedom of atrial fibrillation) over an average follow-up of 18 months."
        }, 
        "brief_title": "A French Multi-centric Atrial Fibrillation Catheter Ablation Survey", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Observation of Outcome After Catheter Ablation of Atrial Fibrillation", 
        "condition_browse": {
            "mesh_term": "Atrial Fibrillation"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  all patients undergoing catheter ablation of atrial fibrillation or left atrial\n             flutter\n\n        Exclusion Criteria:\n\n          -  patients undergoing catheter ablation of other types of arrhythmia"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "All patients undergoing catheter ablation in one of the registry centers"
            }
        }, 
        "firstreceived_date": "August 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01918670", 
            "org_study_id": "FrenchAFAblationSurvey"
        }, 
        "intervention": {
            "arm_group_label": [
                "Pasteur", 
                "Grenoble", 
                "Nantes", 
                "Parly", 
                "Rennes", 
                "Rouen"
            ], 
            "description": "electric pulmonary vein disconnection", 
            "intervention_name": "catheter ablation of atrial fibrillation", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "atrial fibrillation; catheter ablation; relapse; stroke; death", 
        "lastchanged_date": "August 6, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Toulouse", 
                    "country": "France"
                }, 
                "name": "Clinique Pasteur"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "6", 
        "official_title": "A French Multi-centric Atrial Fibrillation Catheter Ablation Survey", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "France: no authority.", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Documentation of atrial fibrillation relapse (symptomatic or asymptomatic) after the first 3 months after the index procedure", 
            "measure": "Atrial fibrillation relapse", 
            "safety_issue": "No", 
            "time_frame": "starting 3 months after the procedure till an average of 18months follow-up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01918670"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Clinique Pasteur", 
            "investigator_full_name": "Serge Boveda", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Documented atrial fibrillation relapse (symptomatic or asymptomatic) in the first 3 months after the index procedure", 
            "measure": "Early atrial fibrillation relapse", 
            "safety_issue": "No", 
            "time_frame": "first 3 months"
        }, 
        "source": "Clinique Pasteur", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "University Hospital of Grenoble, Grenoble, France", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Nouvelle Clinique Nantaise, Nantes, France", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Parly 2 Medical Surgical Center (CMC), Le Chesnay, France", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Rennes University Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University Hospital of Rouen, Rouen, France", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Clinique Pasteur", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2010", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "18 Months", 
        "verification_date": "August 2013"
    }
}